| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Bart A Ellenbroek, Eric P M Prinsse. Can 5-HT3 antagonists contribute toward the treatment of schizophrenia? Behavioural pharmacology. vol 26. issue 1-2. 2015-09-03. PMID:25356732. |
since then, considerable attention has focused on the interaction between dopamine and 5-ht and it is now well accepted that most antipsychotics (especially the second-generation drugs) modulate both dopaminergic and serotonergic receptors. |
2015-09-03 |
2023-08-13 |
human |
| Erik M Mueller, Christin Burgdorf, Mira-Lynn Chavanon, Desiree Schweiger, Jürgen Hennig, Jan Wacker, Gerhard Stemmle. The COMT Val158Met polymorphism regulates the effect of a dopamine antagonist on the feedback-related negativity. Psychophysiology. vol 51. issue 8. 2015-08-28. PMID:24773408. |
consistent with dopamine accounts of internal and external feedback processing, prior work showed that the dopamine d2 receptor antagonist sulpiride modulates the relationship between the dopaminergic comt val158met polymorphism and the error-related negativity (ern). |
2015-08-28 |
2023-08-13 |
human |
| Masahiko Funada, Tomohisa Mori, Jun Maeda, Yuko Tsuda, Sachiko Komiya, Norifumi Shimizu, Junzo Kamei, Tsutomu Suzuk. Splenectomy modifies hyperactive states of the dopaminergic system induced by morphine in C57BL/6J-bg(J)/bg(J) (beige-J) mice. European journal of pharmacology. vol 742. 2015-08-25. PMID:25179571. |
we previously showed that beige-j mice exhibited greater locomotor activity and dopamine turnover, whereas splenectomy reduced this hyperlocomotion and dopamine turnover, which suggests that beige-j mice could be an experimental animal model for investigating hyperactivation of the dopaminergic system, and that the spleen may contribute to the susceptibility to activation of the dopaminergic system. |
2015-08-25 |
2023-08-13 |
mouse |
| YuYing Huang, JunFang Chen, Ying Chen, YingHan Zhuang, Mu Sun, Thomas Behnisc. The neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) alters hippocampal excitatory synaptic transmission by modulation of the GABAergic system. Frontiers in cellular neuroscience. vol 9. 2015-08-24. PMID:26300734. |
moreover, the hippocampus contains dopaminergic fibers, which are projecting from the ventral tegmental area, sn and pars compacta and contain the whole machinery required for dopamine synthesis making them sensitive to mptp and mpp(+). |
2015-08-24 |
2023-08-13 |
mouse |
| Marco Cosentino, Franca Marino, Georges J M Maestron. Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives. Frontiers in cellular neuroscience. vol 9. 2015-08-24. PMID:26300737. |
evidence has since increased showing that adrenergic nerves in the bm release noradrenaline and possibly also dopamine, which act on adrenoceptors and dopaminergic receptors (dr) expressed on hematopoietic cells and affect cell survival, proliferation, migration and engraftment ability. |
2015-08-24 |
2023-08-13 |
Not clear |
| Grant L Lin, Candace B Borders, Leslie J Lundewall, Cara L Wellma. D1 receptors regulate dendritic morphology in normal and stressed prelimbic cortex. Psychoneuroendocrinology. vol 51. 2015-08-21. PMID:25305546. |
dopamine release in mpfc increases during stress, and chronic administration of dopaminergic agonists results in dendritic remodeling. |
2015-08-21 |
2023-08-13 |
rat |
| Grant L Lin, Candace B Borders, Leslie J Lundewall, Cara L Wellma. D1 receptors regulate dendritic morphology in normal and stressed prelimbic cortex. Psychoneuroendocrinology. vol 51. 2015-08-21. PMID:25305546. |
these findings indicate that dopaminergic transmission in mpfc during stress contributes directly to the stress-induced retraction of apical dendrites, while dopamine transmission in the absence of stress is important in maintaining normal dendritic morphology. |
2015-08-21 |
2023-08-13 |
rat |
| Jeffrey L Cummings, Michael J Fine, Igor D Grachev, C Rick Jarecke, Meridith K Johnson, Phillip H Kuo, Kenneth L Schaecher, Joyce A Oberdorf, Michael Rezak, David E Riley, Daniel Truon. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™). The American journal of managed care. vol 20. issue 5 Suppl. 2015-08-20. PMID:24773455. |
in 2011, the us food and drug administration approved ioflupane i-123 injection (datscantm) for striatal dopamine transporter visualization using single-photon emission computed tomography (spect) imaging, which provides an effective tool for assessing striatal dopaminergic deficiency. |
2015-08-20 |
2023-08-13 |
human |
| Rozita H Anderberg, Christine Anefors, Filip Bergquist, Hans Nissbrandt, Karolina P Skibick. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior. Physiology & behavior. vol 136. 2015-08-19. PMID:24560840. |
the literature focuses primarily on the nucleus accumbens as the key dopaminergic target in which enhanced dopamine signaling is associated with reward. |
2015-08-19 |
2023-08-12 |
rat |
| D James Surmeier, Steven M Graves, Weixing She. Dopaminergic modulation of striatal networks in health and Parkinson's disease. Current opinion in neurobiology. vol 29. 2015-08-19. PMID:25058111. |
in the last couple of years, there have been significant advances in our understanding of how dopamine modulates striatal circuits underlying goal-directed behaviors and how therapeutic interventions intended to normalize disordered dopaminergic signaling can go awry. |
2015-08-19 |
2023-08-13 |
Not clear |
| Suja Sadasivan, Joseph H Friedma. Experience with DaTscan at a tertiary referral center. Parkinsonism & related disorders. vol 21. issue 1. 2015-08-19. PMID:25465746. |
functional imaging of the dopamine transporter (dat) defines integrity of the striatal dopaminergic system and provides a marker for presynaptic neuronal degeneration. |
2015-08-19 |
2023-08-13 |
Not clear |
| Andrew Oster, Philippe Faure, Boris S Gutki. Mechanisms for multiple activity modes of VTA dopamine neurons. Frontiers in computational neuroscience. vol 9. 2015-08-18. PMID:26283955. |
midbrain ventral segmental area (vta) dopaminergic neurons send numerous projections to cortical and sub-cortical areas, and diffusely release dopamine (da) to their targets. |
2015-08-18 |
2023-08-13 |
Not clear |
| Daniel Rial, Pablo Pandolfo, Rafael M Bitencourt, Fabrício A Pamplona, Karin M Moreira, Débora Hipolide, Patrícia A Dombrowski, Claudio Da Cunha, Roger Walz, Rodrigo A Cunha, Reinaldo N Takahashi, Rui D Predige. Cellular prion protein (PrP(C)) modulates ethanol-induced behavioral adaptive changes in mice. Behavioural brain research. vol 271. 2015-08-14. PMID:24975422. |
we recently showed that cellular prion protein (prp(c)) affects the homeostasis of the dopaminergic system by interfering with dopamine synthesis, content, receptor density and signaling pathways in different brain areas. |
2015-08-14 |
2023-08-13 |
mouse |
| David N Hauser, April A Dukes, Amanda D Mortimer, Teresa G Hasting. Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. Free radical biology & medicine. vol 65. 2015-08-11. PMID:23816523. |
dopaminergic neurons may be more sensitive to these stressors because they contain dopamine (da), a molecule that oxidizes to the electrophilic dopamine quinone (daq) which can covalently bind nucleophilic amino acid residues such as cysteine. |
2015-08-11 |
2023-08-12 |
rat |
| Puja Tanwani, Bruce A Fernie, Ana V Nikčević, Marcantonio M Spad. A systematic review of treatments for Impulse Control Disorders and related behaviours in Parkinson's disease. Psychiatry research. vol 225. issue 3. 2015-08-11. PMID:25560480. |
related to icds is the dopamine dysregulation syndrome (dds), which is characterised by an addiction-like consumption of dopaminergic medication and punding. |
2015-08-11 |
2023-08-13 |
Not clear |
| Hai-Bo Li, Lin Lin, Li-Ye Yang, Chao Xi. Dopaminergic facilitation of GABAergic transmission in layer III of rat medial entorhinal cortex. The Chinese journal of physiology. vol 58. issue 1. 2015-08-06. PMID:25687491. |
the medial entorhinal cortex (mec) receives a dense dopaminergic innervation and expresses dopamine receptors. |
2015-08-06 |
2023-08-13 |
rat |
| Takuya Funayama, Yumiko Ikeda, Amane Tateno, Hidehiko Takahashi, Yoshiro Okubo, Haruhisa Fukayama, Hidenori Suzuk. Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens. Psychopharmacology. vol 231. issue 16. 2015-08-04. PMID:24682502. |
the nucleus accumbens (nac) works as a key brain structure of the reward system, in which reward-related neural activity is well correlated with dopamine release from mesolimbic dopaminergic neurons. |
2015-08-04 |
2023-08-12 |
Not clear |
| Taysa B Bassani, Raisa W Gradowski, Tiago Zaminelli, Janaína K Barbiero, Ronise M Santiago, Suelen L Boschen, Claudio da Cunha, Marcelo M S Lima, Roberto Andreatini, Maria A B F Vita. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats. Brain research. vol 1593. 2015-08-04. PMID:25301688. |
we verified that prolonged melatonin treatment after dopaminergic lesion did not alter motor function but produced antidepressant-like effects in the forced swim test, prevented the rotenone-induced reduction of striatal dopamine, and partially prevented tyrosine hydroxylase immunoreactivity loss in the snpc. |
2015-08-04 |
2023-08-13 |
rat |
| Jiaming Mei, Chaoshi Ni. Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations. Molecular medicine reports. vol 11. issue 2. 2015-07-30. PMID:25373844. |
effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-ohda administrations. |
2015-07-30 |
2023-08-13 |
rat |
| Joannalee C Campbell, Shiveindra B Jeyamohan, Priscilla De La Cruz, Nita Chen, Damian Shin, Julie G Pilitsi. Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression. Behavioural brain research. vol 275. 2015-07-24. PMID:25205367. |
one potential complication of treating parkinson's disease (pd) with dopaminergic drugs is dopamine dysregulation syndrome, an addiction-like response to the drug therapy. |
2015-07-24 |
2023-08-13 |
rat |